|
|
Volumn 362, Issue 11, 2010, Pages 1046-1048
|
|
Niacin compared with ezetimibe [1]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
EZETIMIBE;
HIGH DENSITY LIPOPROTEIN CHOLESTEROL;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
LIPOPROTEIN;
LOW DENSITY LIPOPROTEIN CHOLESTEROL;
NICOTINIC ACID;
SIMVASTATIN;
TRIACYLGLYCEROL;
AZETIDINE DERIVATIVE;
HYPOCHOLESTEROLEMIC AGENT;
VASODILATOR AGENT;
ARTERIAL WALL THICKNESS;
BLOOD PRESSURE;
CARDIOVASCULAR DISEASE;
CAROTID ARTERY;
CHOLESTEROL BLOOD LEVEL;
DRUG EFFICACY;
DRUG RELEASE;
HUMAN;
HYPERCHOLESTEROLEMIA;
HYPERTENSION;
INFLAMMATION;
LETTER;
PRIORITY JOURNAL;
TREATMENT OUTCOME;
CONTROLLED STUDY;
CORONARY ARTERY ATHEROSCLEROSIS;
DISEASE COURSE;
RISK REDUCTION;
TRIACYLGLYCEROL BLOOD LEVEL;
CORONARY ARTERY DISEASE;
DRUG COMBINATION;
DRUG EFFECT;
NOTE;
BLOOD;
INTIMA;
TUNICA MEDIA;
ANTICHOLESTEREMIC AGENTS;
AZETIDINES;
BLOOD PRESSURE;
CAROTID ARTERIES;
CORONARY DISEASE;
DRUG THERAPY, COMBINATION;
HUMANS;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
NIACIN;
VASODILATOR AGENTS;
CHOLESTEROL, LDL;
TUNICA INTIMA;
TUNICA MEDIA;
|
|
EID: 77949572838
PISSN: 00284793
EISSN: 15334406
Source Type: Journal
DOI: 10.1056/NEJMc0912942 Document Type: Letter |
|
Times cited : (10)
|
|
References (5)
|
